Filing Details
- Accession Number:
- 0000878088-10-000033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-16 13:00:00
- Reporting Period:
- 2010-04-15
- Filing Date:
- 2010-04-16
- Accepted Time:
- 2010-04-16 16:59:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 878088 | Par Pharmaceutical Companies Inc. | PRX | Pharmaceutical Preparations (2834) | 223122182 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1182633 | Md Melvin Sharoky | C/O Par Pharmaceutical Companies Inc. 300 Tice Blvd Woodcliff Lake NJ 07677 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-04-15 | 10,610 | $27.50 | 9,390 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-04-15 | 300 | $27.49 | 9,090 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-04-15 | 900 | $27.48 | 8,190 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-04-15 | 1,400 | $27.47 | 6,790 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-04-15 | 600 | $27.46 | 6,190 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-04-15 | 300 | $27.44 | 5,890 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-04-15 | 100 | $27.43 | 5,790 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-04-15 | 2,500 | $27.40 | 3,290 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-04-15 | 3,290 | $27.39 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Deferred Unit Award/Stock Units | $0.00 | 12,147 | 12,147 | Direct | ||
| Common Stock | Restricted Stock Units | $0.00 | 18,172 | 18,172 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 12,147 | 12,147 | Direct | |
| 18,172 | 18,172 | Direct |
Footnotes
- Each stock unit is the economic equivalent of one share of common stock, which stock will be distributed only upon termination of the Reporting Person's services as a director of the Issuer.
Billionaire Hedge Funds
